Intellia Therapeutics Inc

Healthcare · Biotechnology

11.70$ -5.3% vs. previous close Closing price · As of: Oct 7, 2026

Statements

Balance Sheet

Intellia Therapeutics Inc (NTLA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 857 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet NTLA
Line item	Q3 16	Q4 16	Q1 17	Q2 17	Q3 17	Q4 17	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Total Assets	301	299	279	265	249	376	360	340	321	347	344	352	347	334	315	491	459	676	717	672	1,335	1,294	1,203	1,110	1,084	1,520	1,418	1,323	1,243	1,301	1,260	1,192	1,173	1,191	986	899	925	842	759	857
Current Assets	293	281	261	246	229	355	338	318	299	325	304	307	296	289	270	446	416	617	601	549	815	769	875	895	859	1,217	964	940	893	998	884	757	711	640	551	496	582	528	466	528
Cash	291	273	258	241	222	341	328	306	293	59	47	49	38	57	81	362	180	160	142	130	335	123	133	148	141	524	294	172	168	227	172	131	120	189	127	156	193	155	135	106
Cash & Short-Term Investments	291	273	258	241	222	341	328	306	293	314	297	271	286	280	250	437	408	597	584	529	798	749	855	874	828	1,193	934	908	855	912	791	691	658	602	504	460	511	450	376	438
Receivables	1.1	6.5	2.4	2.8	4.5	10	7.5	8.6	2.8	7.5	3.6	4.2	3.6	4.6	13	3.9	1.2	2.1	1.0	2.0	2.5	2.0	1.8	2.9	4.0	3.8	4.9	5.1	6.5	36	36	12	8.9	8.5	11	11	11	9.5	9.1	7.3
Inventory	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	–	0.0	–	–	0.0	-19	0.0	0.0	–	-337	0.0	-33	0.0	-69	-225	-164	-138	–	0.0	–	–	–	–	–	–	–	–	–
Property, Plant & Equipment	5.5	11	11	13	14	15	16	17	17	17	38	38	38	37	42	40	16	16	16	96	20	21	24	26	27	28	32	157	–	–	–	–	–	–	–	–	–	–	–	–
Goodwill	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Intangible Assets	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Total Liabilities	83	89	79	77	73	76	64	60	58	69	80	76	71	64	67	139	129	149	171	177	228	254	249	230	260	285	227	218	206	251	223	220	211	319	206	184	177	171	138	129
Current Liabilities	23	31	25	26	26	31	26	25	26	41	39	38	38	36	35	59	56	64	61	74	98	126	126	124	131	127	103	100	92	115	98	105	106	111	113	95	94	104	76	79
Short-Term Debt	–	–	–	–	–	–	–	–	–	–	4.4	5.1	5.5	5.7	5.7	5.8	6.2	5.7	8.3	7.4	8.7	9.1	9.3	9.6	14	17	16	17	17	19	19	19	19	20	39	27	27	26	19	23
Accounts Payable	0.7	4.7	1.4	2.3	2.2	2.2	1.9	0.3	1.8	2.7	3.7	1.8	4.5	3.9	3.9	0.0	7.8	10	8.7	6.9	7.5	9.7	10	7.5	4.4	5.2	6.9	12	3.6	7.5	14	19	13	15	12	9.8	13	20	19	12
Long-Term Debt	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	–	15	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Shareholders' Equity	218	210	200	188	176	301	295	279	263	278	264	277	276	270	248	352	330	527	546	495	1,107	1,040	954	881	825	1,236	1,191	1,105	1,037	1,050	1,036	971	963	872	780	715	748	671	621	728
Retained Earnings	-43	-54	-66	-82	-97	-121	-137	-159	-182	-201	-223	-249	-273	-301	-333	-365	-393	-435	-481	-550	-622	-703	-850	-951	-1,064	-1,177	-1,280	-1,404	-1,526	-1,658	-1,766	-1,913	-2,049	-2,177	-2,292	-2,393	-2,494	-2,590	-2,686	-2,793
Shares Outstanding	34	35	35	35	35	39	42	43	43	44	45	46	49	49	50	53	59	61	67	68	74	74	75	76	76	81	88	88	89	90	96	97	101	102	104	104	110	108	118	133

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings